新加坡高毒力碳青霉烯耐药肺炎克雷伯菌获得blaKPC-2质粒
该研究分析新加坡医院2010-2015年556株碳青霉烯耐药肺炎克雷伯菌,发现来自7例患者的18株菌同时具有高毒力特征,均携带含blaKPC-2的密切相关质粒pKPC2,背景为荚膜血清型K1、K2和K20。pKPC2可高效传播且在宿主体内长期稳定,提示碳青霉烯耐药高毒力肺炎克雷伯菌存在传播风险。
要点
- 556株碳青霉烯耐药肺炎克雷伯菌中检出7例患者携带高毒力特征菌株。
- 所有高毒力菌株均含blaKPC-2质粒pKPC2,荚膜血清型为K1、K2或K20。
- pKPC2可高效传播并在宿主体内长期稳定,且可获得额外耐药基因。
核心结论
- 碳青霉烯耐药与高毒力特征在肺炎克雷伯菌中融合,提示新加坡可能出现碳青霉烯耐药高毒力肺炎克雷伯菌传播。
研究设计与样本
- 分析新加坡医院2010-2015年556株碳青霉烯耐药肺炎克雷伯菌分离株,发现来自7例患者的18株菌具有高毒力特征。
主要发现
- 7例患者分离株中5株首次分离菌呈高黏液表型,6株在小鼠中具毒力。
- 所有高毒力菌株均含密切相关质粒pKPC2,携带blaKPC-2,荚膜血清型为K1、K2和K20。
- pKPC2高度可传播且稳定,在无抗菌药物选择压力下于患者体内数月内变化很少。
- 患者体内分离株可获得额外抗菌药物耐药基因。
临床怎么用
- 对碳青霉烯耐药肺炎克雷伯菌应关注高毒力特征(如高黏液表型)及荚膜血清型K1、K2、K20。
- 监测blaKPC-2质粒pKPC2的传播,注意患者体内菌株可获得额外耐药基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The convergence of carbapenem-resistance and hypervirulence genes in Klebsiella pneumoniae has led to the emergence of highly drug-resistant superbugs capable of causing invasive disease. We analyzed 556 carbapenem-resistant K. pneumoniae isolates from patients in Singapore hospitals during 2010-2015 and discovered 18 isolates from 7 patients also harbored hypervirulence features. All isolates contained a closely related plasmid (pKPC2) harboring blaKPC-2, a K. pneumoniae carbapenemase gene, and had a hypervirulent background of capsular serotypes K1, K2, and K20. In total, 5 of 7 first patient isolates were hypermucoviscous, and 6 were virulent in mice. The pKPC2 was highly transmissible and remarkably stable, maintained in bacteria within a patient with few changes for months in the absence of antimicrobial drug selection pressure. Intrapatient isolates were also able to acquire additional antimicrobial drug resistance genes when inside human bodies. Our results highlight the potential spread of carbapenem-resistant hypervirulent K. pneumoniae in Singapore.
引用
- Chen Y, Marimuthu K, Teo J, et al. Acquisition of Plasmid with Carbapenem-Resistance Gene blaKPC2 in Hypervirulent Klebsiella pneumoniae, Singapore. Emerg Infect Dis. 2020. PMID: 32091354. doi:10.3201/eid2603.191230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。